Human prostate cancer risk factors
- PMID: 15495199
- DOI: 10.1002/cncr.20408
Human prostate cancer risk factors
Abstract
Prostate cancer has the highest prevalence of any nonskin cancer in the human body, with similar likelihood of neoplastic foci found within the prostates of men around the world regardless of diet, occupation, lifestyle, or other factors. Essentially all men with circulating androgens will develop microscopic prostate cancer if they live long enough. This review is a contemporary and comprehensive, literature-based analysis of the putative risk factors for human prostate cancer, and the results were presented at a multidisciplinary consensus conference held in Crystal City, Virginia, in the fall of 2002. The objectives were to evaluate known environmental factors and mechanisms of prostatic carcinogenesis and to identify existing data gaps and future research needs. The review is divided into four sections, including 1) epidemiology (endogenous factors [family history, hormones, race, aging and oxidative stress] and exogenous factors [diet, environmental agents, occupation and other factors, including lifestyle factors]); 2) animal and cell culture models for prediction of human risk (rodent models, transgenic models, mouse reconstitution models, severe combined immunodeficiency syndrome mouse models, canine models, xenograft models, and cell culture models); 3) biomarkers in prostate cancer, most of which have been tested only as predictive factors for patient outcome after treatment rather than as risk factors; and 4) genotoxic and nongenotoxic mechanisms of carcinogenesis. The authors conclude that most of the data regarding risk relies, of necessity, on epidemiologic studies, but animal and cell culture models offer promise in confirming some important findings. The current understanding of biomarkers of disease and risk factors is limited. An understanding of the risk factors for prostate cancer has practical importance for public health research and policy, genetic and nutritional education and chemoprevention, and prevention strategies.
(c) 2004 American Cancer Society.
Similar articles
-
The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.Mutat Res. 2005 Aug 25;576(1-2):111-9. doi: 10.1016/j.mrfmmm.2005.02.012. Mutat Res. 2005. PMID: 15885713 Review.
-
Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.Oncol Nurs Forum. 1994 Oct;21(9):1504-11. Oncol Nurs Forum. 1994. PMID: 7816677 Review.
-
Prostate carcinogenesis and inflammation: emerging insights.Carcinogenesis. 2005 Jul;26(7):1170-81. doi: 10.1093/carcin/bgh317. Epub 2004 Oct 21. Carcinogenesis. 2005. PMID: 15498784 Review.
-
Prevention of hormone-related cancers: prostate cancer.J Clin Oncol. 2005 Jan 10;23(2):368-77. doi: 10.1200/JCO.2005.08.027. J Clin Oncol. 2005. PMID: 15637399 Review.
-
[Nutrition and pharmacological treatment for prevention of prostate cancer].Harefuah. 2006 Jan;145(1):47-51, 76-7. Harefuah. 2006. PMID: 16450727 Review. Hebrew.
Cited by
-
Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features.Int Braz J Urol. 2015 Mar-Apr;41(2):344-52. doi: 10.1590/S1677-5538.IBJU.2015.02.23. Int Braz J Urol. 2015. PMID: 26005978 Free PMC article.
-
Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update.Syst Rev. 2022 Oct 26;11(1):230. doi: 10.1186/s13643-022-02099-9. Syst Rev. 2022. PMID: 36289518 Free PMC article.
-
Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring.Alcohol Clin Exp Res. 2013 Nov;37(11):1901-9. doi: 10.1111/acer.12171. Epub 2013 Jul 26. Alcohol Clin Exp Res. 2013. PMID: 23889735 Free PMC article.
-
A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers.Front Genet. 2022 Nov 16;13:1066118. doi: 10.3389/fgene.2022.1066118. eCollection 2022. Front Genet. 2022. PMID: 36468011 Free PMC article.
-
Prognostic value of estrogen receptors in patients who underwent prostatectomy for non‑metastatic prostate cancer.Oncol Lett. 2023 Jan 9;25(2):78. doi: 10.3892/ol.2023.13664. eCollection 2023 Feb. Oncol Lett. 2023. PMID: 36742361 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical